The FDA Authorizes Eli Lily's COVID-19 Antibody Treatment for Emergency Use

Click the image below to enlarge the infographic.
  • The United States Food and Drug Administration (FDA) has granted an emergency use authorization for drugmaker Eli Lilly's COVID-19 antibody treatment
  • The drug company said that in clinical trials, the drug successfully reduced viral load, COVID-19 symptoms, and hospitalizations in patients with mild to moderate disease
  • The drug is one of several antibody treatments being developed for the treatment of coronavirus
  • The pharmaceutical company submitted an application on October 7 for its emergency approval after trial results showed outstanding findings with minimal side effects
  • The company plans to produce up to 1 million doses of the drug by late December